967 related articles for article (PubMed ID: 31341421)
41. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis.
Taxman DJ; Swanson KV; Broglie PM; Wen H; Holley-Guthrie E; Huang MT; Callaway JB; Eitas TK; Duncan JA; Ting JP
J Biol Chem; 2012 Sep; 287(39):32791-9. PubMed ID: 22843689
[TBL] [Abstract][Full Text] [Related]
42. P2X7 receptor-mediated leukocyte recruitment and Porphyromonas gingivalis clearance requires IL-1β production and autocrine IL-1 receptor activation.
Almeida-da-Silva CLC; Ramos-Junior ES; Morandini AC; Rocha GDC; Marinho Y; Tamura AS; de Andrade KQ; Bellio M; Savio LEB; Scharfstein J; Ojcius DM; Coutinho-Silva R
Immunobiology; 2019 Jan; 224(1):50-59. PubMed ID: 30429052
[TBL] [Abstract][Full Text] [Related]
43. Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis.
Saito Y; Fujii R; Nakagawa KI; Kuramitsu HK; Okuda K; Ishihara K
Oral Microbiol Immunol; 2008 Feb; 23(1):1-6. PubMed ID: 18173791
[TBL] [Abstract][Full Text] [Related]
44. Expression of human caspase-4 in the gingival epithelium affected with periodontitis: Its involvement in Porphyromonas gingivalis-challenged gingival epithelial cells.
Kantrong N; Buranaphatthana W; Hormdee D; Suwannarong W; Chaichit R; Pattanaporn K; Klanrit P; Krisanaprakornkit S
Arch Oral Biol; 2022 Aug; 140():105466. PubMed ID: 35640321
[TBL] [Abstract][Full Text] [Related]
45. Potential role of periodontal pathogens in compromising epithelial barrier function by inducing epithelial-mesenchymal transition.
Abdulkareem AA; Shelton RM; Landini G; Cooper PR; Milward MR
J Periodontal Res; 2018 Aug; 53(4):565-574. PubMed ID: 29704258
[TBL] [Abstract][Full Text] [Related]
46. Effects of Sulfonylureas on Periodontopathic Bacteria-Induced Inflammation.
Kawahara Y; Kaneko T; Yoshinaga Y; Arita Y; Nakamura K; Koga C; Yoshimura A; Sakagami R
J Dent Res; 2020 Jul; 99(7):830-838. PubMed ID: 32202959
[TBL] [Abstract][Full Text] [Related]
47. Porphyromonas gingivalis-impaired innate immune response via NLRP3 proteolysis in endothelial cells.
Huck O; Elkaim R; Davideau JL; Tenenbaum H
Innate Immun; 2015 Jan; 21(1):65-72. PubMed ID: 24583910
[TBL] [Abstract][Full Text] [Related]
48. Porphyromonas gingivalis entry into gingival epithelial cells modulated by Fusobacterium nucleatum is dependent on lipid rafts.
Saito A; Kokubu E; Inagaki S; Imamura K; Kita D; Lamont RJ; Ishihara K
Microb Pathog; 2012; 53(5-6):234-42. PubMed ID: 23034475
[TBL] [Abstract][Full Text] [Related]
49. Catechin ameliorates Porphyromonas gingivalis-induced inflammation via the regulation of TLR2/4 and inflammasome signaling.
Lee HA; Song YR; Park MH; Chung HY; Na HS; Chung J
J Periodontol; 2020 May; 91(5):661-670. PubMed ID: 31473995
[TBL] [Abstract][Full Text] [Related]
50. In vitro cytokine responses to periodontal pathogens: generalized aggressive periodontitis is associated with increased IL-6 response to Porphyromonas gingivalis.
Borch TS; Holmstrup P; Bendtzen K; Nielsen CH
Scand J Immunol; 2010 Jun; 71(6):440-6. PubMed ID: 20500696
[TBL] [Abstract][Full Text] [Related]
51. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
52. Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice.
Lei L; Li H; Yan F; Xiao Y
PLoS One; 2013; 8(8):e71849. PubMed ID: 23977160
[TBL] [Abstract][Full Text] [Related]
53. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola.
Ding Y; Haapasalo M; Kerosuo E; Lounatmaa K; Kotiranta A; Sorsa T
J Clin Periodontol; 1997 Apr; 24(4):237-48. PubMed ID: 9144046
[TBL] [Abstract][Full Text] [Related]
54. Interleukin 1, interleukin 6 and transforming growth factor-beta production by human gingival mononuclear cells following stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum.
Gemmell E; Seymour GJ
J Periodontal Res; 1993 Mar; 28(2):122-9. PubMed ID: 8386762
[TBL] [Abstract][Full Text] [Related]
55. Characteristics of Porphyromonas gingivalis lipopolysaccharide in co-culture with Fusobacterium nucleatum.
Lee SH; Baek DH
Mol Oral Microbiol; 2013 Jun; 28(3):230-8. PubMed ID: 23347381
[TBL] [Abstract][Full Text] [Related]
56. Cholesterol crystals enhance TLR2- and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis.
Køllgaard T; Enevold C; Bendtzen K; Hansen PR; Givskov M; Holmstrup P; Nielsen CH
PLoS One; 2017; 12(2):e0172773. PubMed ID: 28235036
[TBL] [Abstract][Full Text] [Related]
57. Antibacterial activity of povidone-iodine against an artificial biofilm of Porphyromonas gingivalis and Fusobacterium nucleatum.
Hosaka Y; Saito A; Maeda R; Fukaya C; Morikawa S; Makino A; Ishihara K; Nakagawa T
Arch Oral Biol; 2012 Apr; 57(4):364-8. PubMed ID: 21958970
[TBL] [Abstract][Full Text] [Related]
58. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.
Gibson FC; Genco CA
Curr Pharm Des; 2007; 13(36):3665-75. PubMed ID: 18220804
[TBL] [Abstract][Full Text] [Related]
59. Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis.
Yamaguchi Y; Kurita-Ochiai T; Kobayashi R; Suzuki T; Ando T
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25663345
[TBL] [Abstract][Full Text] [Related]
60. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum.
Bolstad AI; Jensen HB; Bakken V
Clin Microbiol Rev; 1996 Jan; 9(1):55-71. PubMed ID: 8665477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
